top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
Log in / Sign up
ipharmaservices
Jun 27, 2024
UCB’s Epilepsy Drug Briviact (brivaracetam) Gains Approval in Japan for Focal Onset Seizures | 2024 | iPharmaCenter
ipharmaservices
Jun 24, 2024
Takeda Announces Approval of Livtencity in Japan for Resistant Post-Transplant Cytomegalovirus (CMV) Infection/Disease
ipharmaservices
Feb 17, 2024
Japan Drug Approvals | 日本の医薬品承認 | ニュース | 日本のニュース速報 | 健康管理 | 2024 | iPharmaCenter
ipharmaservices
Dec 31, 2023
Japan Drug Approvals | 2023 | MHLW | PMDA | iPharmaCenter
ipharmaservices
Mar 12, 2021
Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
ipharmaservices
Jan 5, 2021
Lynparza was approved for three more indications in Japan
ipharmaservices
Aug 25, 2020
Merck’s Keytruda received one more indication and dosage form approval in Japan
ipharmaservices
Jun 3, 2020
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
ipharmaservices
May 30, 2020
Astellas received approval for Xtandi in Japan for prostate cancer
ipharmaservices
Mar 29, 2020
AstraZeneca's Lokelma approved in Japan
bottom of page